FDA approves Gilead’s Bixlenvo once-daily HIV combination tablet on August 28, 2026 Approved bictegravir Bixlenvo Gilead Sciences HIV Lenacapavir single-tablet Treatment Protocols United States Food and Drug Administration viral suppression +
US-Backed Group Reports Success with New Tuberculosis Treatment in Phase 2 Study on November 19, 2025 Clinical Trials drug-resistant TB linezolid Phase 2 clinical trial pretomanid sorfequiline SPaL TB Alliance Treatment Protocols Tuberculosis U.S. ultra-short regimen +
FDA Approves Updated Dosing for Lilly's Kisunla to Lower Brain Swelling Risk on July 12, 2025 Alzheimer 's disease Cerebral Edema dosing Eli Lilly Kisunla label update Neuregulins Safety Treatment Protocols United States Food and Drug Administration +